Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-21-009686
Filing Date
2021-05-10
Accepted
2021-05-10 16:06:51
Documents
6
Period of Report
2021-05-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A auriniapharmaceuticalsinc2.htm DEF 14A 1676059
2 aurinalogo1.jpg GRAPHIC 11010
3 infographic31.jpg GRAPHIC 142046
4 proxycard_11.jpg GRAPHIC 127888
5 proxycard_21.jpg GRAPHIC 124158
6 votingmethods1.jpg GRAPHIC 71916
  Complete submission text file 0001628280-21-009686.txt   2307548
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36421 | Film No.: 21907186
SIC: 2834 Pharmaceutical Preparations